60
Basic Biosafety Principles

Biosafety

Embed Size (px)

Citation preview

Page 1: Biosafety

Basic Biosafety Principles

Page 2: Biosafety

Principles and practices employed to protect laboratory personnel and the environment from exposure or infection while working with living organisms, biological materials, or agents.

Included are any materials that may be potentially infectious.

Includes recombinant DNA research

What is Biosafety?

Page 3: Biosafety

The “agent” is the what creates risk

Risks to the worker or environment are often unknown

Determining “acceptable risk”?

Agents and Risks

Page 4: Biosafety

There is always risk! The risk must be identified The risk is evaluated The risk must be measured Plan to minimize the risk

Assessing Risk

Page 5: Biosafety

Assessment is conducted by a Biosafety Professional in partnership with and based on information provided by the Principal Investigator

The assessment is presented to the Institutional Biosafety Committee (IBC) for approval

Who Determines Acceptable Risk?

Page 6: Biosafety

Understand the biology of the agent Susceptibility and transmission within

the host Hazards associated with equipment

and procedures Goal:

Provide the highest practical protection and the lowest practical exposure

Identifying Risk

Page 7: Biosafety

Worst case scenario -What might happen?

Likelihood of an event

Seriousness of the incident

Actions needed to resolve the problems

Evaluating Risk Acceptability

Page 8: Biosafety

Since there is no such thing as “no risk” “Safe” means risk has been judged acceptable Judging risk is a subjective- humans make

decisions Measuring risk is objective- use available

guidelines, data, and documentation Keep records of how determinations were made

due to subjective nature of the process

What is Acceptable Risk?

Page 9: Biosafety

Sunday, Sep. 20, 2009

Did the Plague Kill Illinois Scientist?By AP

(AP / CHICAGO) — The University of Chicago Medical Center says the infection that killed a scientist may be connected to bacteria he researched that causes the plague.

The university said Saturday that its researcher studied the genetics of harmful bacteria including Yersinia pestis, which causes the illness. He died Sept. 13. His name and age haven't been

released

The medical center says the bacteria he worked with was a weakened strain that isn't known to cause illness in healthy adults. The strain was approved by the Centers for Disease Control and

Prevention for laboratory studies.

An autopsy found no obvious cause of death but did find the presence of the bacteria. More tests are planned. No other illnesses have been reported.

Page 10: Biosafety

Biosafety in Various DisciplinesBiosafety is related to several fields

ECOLOGY: referring to imported life forms not indigenous to the region (Reggie the alligator)

AGRICULTURE: reducing the risk of alien viral or transgenic genes, or prions such as BSE/"MadCow“; reducing the risk of food bacterial contamination

MEDICINE: referring to organs or tissues from biological origin, or genetic therapy products, virus; levels of lab containment protocols BSL-1, 2, 3, 4 in rising order of danger

CHEMISTRY: i.e., nitrates in water, PCB levels affecting fertility

EXOBIOLOGY: i.e., NASA's policy for containing alien microbes that may exist on space samples - sometimes called "biosafety level 5"

Page 11: Biosafety

Biosafety in Academic Research Research Universities: Promoting safe laboratory

practices, and procedures; proper use of containment equipment and facilities; provides advice on laboratory design and risk assesment of experiments involving infectious agents, rDNA in-vitro and in-vivo.

Bottom Line: Risk & Containment

Page 12: Biosafety

Biohazard Symbol Charles Baldwin at

National Cancer Institute at NIH.

Symbol to be “memorable but meaningless” so it could be learned.

Blaze orange – most visible under harsh conditions

Page 13: Biosafety

Biosafety Issues Laboratory Safety Bloodborne pathogens (BBP) Recombinant DNA (rDNA) Biological waste disposal Infectious substance and diagnostic specimen shipping

Page 14: Biosafety

Biosafety Issues (con’t.)

Respiratory Protection Bioterrorism and Select agents Mold and indoor air quality Occupational safety and health in the use

of research animals Biohazards used in animal models

Page 15: Biosafety

Biohazardous Materials Viruses Bacteria Fungi Chlamydiae/Rickettsiae Prions Recombinant DNA

Page 16: Biosafety

Biohazardous materials Transgenic Plants, Animals and Insects

     

     

     

   

     

Page 17: Biosafety

Transgenic Insects

Page 18: Biosafety

Biohazardous Materials

Human and Primate Cells, Tissues, and Body Fluids

Brain Tissue from Demented Patients Viral Vectors

Replication deficient viruses

Page 19: Biosafety

Biosafety In Microbiologicaland Biomedical Laboratories“BMBL” (acronym)

CDC/NIH PublicationSafety “Guidelines”Regulations of Institution receives NIH funding

Code of Practice and “Gold” Standard in Industry anlGold Standard

Clinical & Research Lab.Lab. Animal Facilities

Biosafety Concepts

HHS Publication No. (CDC) 93-8395

Page 20: Biosafety

The New BMBL

Early print edition….

Emphasis on “Risk

& Containment”

Page 21: Biosafety

The BMBL continues to be published by the CDC and the NIH 5th edition is now at the printers

http://www.cdc.gov/od/ohs/biosfty/bmbl5/bmbl5toc.htm

Biosafety ConceptsThe BMBL

Page 22: Biosafety

Are the NIH Guidelines Optional?

“Guidelines” does not mean “optional”

They are a term and condition of NIH funding for recombinant DNA research.

From Kathryn Harris, NIH, OBA

Page 23: Biosafety

Biosafety Concepts from the BMBL

Principles of Biosafety Practice and Procedures

Standard Practices Special Practices & Considerations

Safety Equipment Facility Design and Construction Increasing levels of protection

Page 24: Biosafety

Principles of Biosafety

Biosafety Levels 1-4 (BSL) Increasing levels of employee and environmental protection Guidelines for working safely in research & medical

laboratory facilities

Animal Biosafety Levels 1- 4 (ABSL)

Laboratory animal facilities Animal models that support research Guidelines for working safely in animal research facilities

Page 25: Biosafety

Biosafety ConceptsThe BMBL

(1) Standard Microbiological Practices Most important concept / Strict adherence Aware of potential hazard Trained & proficient in techniques Supervisors responsible for:

Appropriate Laboratory facilities Personnel & Training

Special practices & precautions Occupational Health Programs

Page 26: Biosafety

Biosafety IssuesThe BMBL

(2) Safety Equipment Primary Containment Barrier Minimize exposure to hazard

Prevent contact / Contain aerosols Engineering controls/ equipment Personal Protective Equipment (PPE)

Gloves, gowns, Respirator, Face shield, Booties Biological Safety Cabinets Covered or ventilated animal cage systems

Page 27: Biosafety

Biosafety ConceptsThe BMBL

(3) Facility Design and Construction

Secondary Barrier/ Engineering controls

Contributes to worker protection Protects outside the laboratory

Environment & Neighborhood Ex. Building & Lab design,

Ventilation, Autoclaves, Cage wash facilities, etc.

Page 28: Biosafety

Laboratory Design

“Warehouse Type Lab”

Page 29: Biosafety

Discussion

What are some of the negatives and positives of this open lab concept?

Page 30: Biosafety

Biosafety Level-1 Concepts of Biosafety

Biosafety Level-1 (BSL-1 or ABSL-1) Well characterized agents Agents not known to cause disease (in healthy human

adults; now healthy immunocompetent adults)

Prophylactic treatment available Open bench procedures Animals in open cage system or open environment

(outdoors) Good laboratory practices

Page 31: Biosafety

Risk Group 1 Agents E.coli K-12 Transgenic Plants Plasmids Fungi Mold Yeast

Page 32: Biosafety

BSL-1 Practices

Bench-top work allowed Daily Decontamination Manual pipetting Required Handwashing Red bag waste Bio cabinet not required

(unless creating aerosols) 2˚ containment

Page 33: Biosafety

Risk Group 2 Agents Human or Primate

Cells Herpes Simplex Virus Replication

Incompetent Attenuated Human Immunodeficiency Virus

Patient specimens

Page 34: Biosafety

BSL-2 Practices Concepts of Biosafety

Practices & Procedures Agents associated w/ human disease Treatment for disease available Agent poses moderate hazard to personnel and

environment Direct contact or exposure Percutaneous exposure

Scratch, Puncture, Needle stick Mucus membrane exposure

Eyes, Mouth, open cut

Page 35: Biosafety

BSL-2 Practices

Limited access to lab when work in progress

Daily decontamination Mechanical pipetting Labcoat, safety glasses

and gloves required Red bag & sharps

containers required

Page 36: Biosafety

BSL-2 Practices (con’t)

Biohaz. Sign posted at entrance to lab

Label all equipment (incubators, freezers, etc.)

TC room – negative air flow Documented training Baseline serology or pre-

vaccination may be required

Page 37: Biosafety

Risk Group 3 Agents Human

Immunodeficiency Virus

Mycobacterium tuberculosis

Coxiella burnetii

Page 38: Biosafety

Biosafety Level 3Working in High Containment

Biosafety Level-3 (BSL-3 or ABSL-3)

Indigenous or exotic agents Aerosol transmission Serious health effects Treatment may or may not exist

Page 39: Biosafety

BSL-3 Practices

Public access NOT permitted Daily decontamination after spill and

upon completion of experiment Autoclave required and waste is

disposed at the end of day Required foot activated handwashing

sink and controls No sharps unless absolutely necessary

Page 40: Biosafety

BSL-3 Practices (con’t)

Aerosol minimization procedures required Wrap around disposable clothing is

required. Specialized equipment may be required depending upon procedures

Biohaz. Signs and labels posted Air flow from low hazard to high hazard

“Pressure Mapping”

Page 41: Biosafety

BSL-3 Practices (con’t)

Bench top work not permitted Documented training and personnel competency

certification (for BSL-3 procedures) Baseline serology Spills – report immediately and treat accordingly Vaccinations/post exposure protocols and SOP’s,

Biosafety Manual, Biosafety Officer

Page 42: Biosafety

UCSD’s BSL-3

Page 43: Biosafety

Biosafety Level-4Working in High Containment

Biosafety Level-4 Builds on BSL-3/ ABSL-3 practices Maximum containment facilities Pressurized Containment Suite

BSL-3 + Class III Biosafety Cabinet Chemical decontamination showers Liquid effluent collection / decontamination No BSL-4 labs exist at UCSD

Page 44: Biosafety

Biosafety Level 4 Lassa Fever Virus Ebola Hemmorrhagic

Fever Virus Marburg Virus Herpes B Virus

Page 45: Biosafety

Biosafety ConceptsWorking in High Containment

Biosafety Level-4 (BSL-4 or ABSL-4) Dangerous/exotic agents Life threatening disease Aerosol transmission Agents of unknown risk of transmission or health affects No known treatment

Page 46: Biosafety

Animal Biosafety Level-4Working in High Containment

Page 47: Biosafety

Bacterial:76% from clinical labs8% from research labs

Exposure:60% acquired from inhalation

Other exposures include: digestion, sharps, splashes, direct and indirect contact

Laboratory Acquired Infections (LAI)

Page 48: Biosafety

Viral 16% from clinical labs 70% from research labs

32% from animal related activities

Laboratory Acquired Infections (LAI)

Page 49: Biosafety

General Good Lab Technique

Hygienic Practices No Smoking, Eating, Applying cosmetics, lip

balm, contacts Wash hands after procedures Decontaminate lab bench before and after

work

Page 50: Biosafety

General Operational Practices Proper attire

Minimum – lab coat, safety glasses, gloves Plan your work

Know in advance what you are working with Read available resources (MSDS)

http://www.hc-sc.gc.ca/pphb-dgspsp/msds-ftss/index.html

Page 51: Biosafety

Animal Containment Points

CDC - 1957CDC & UCSD - 2005

Courtesy of Paul Vinson, CDC

Page 52: Biosafety

Discussion # 2 Based on what you know about Biosafety

Levels, Practices and Operational Controls, what are some discussion issues for conducting Biohazard risk assessments?

How do you approach risks when addressing a particular organism?

Page 53: Biosafety
Page 54: Biosafety

Risk Assessment

In-Vitro In-Vivo Human ClinicalTrial

Page 55: Biosafety

Addressing Risk Assessments What is the organism? Is it Wild-type, attenuated, irradiated, or

chemically treated? Look at kill data or kill curves.

What is the max. concentration, volume, infectious dose?

What is the work space like? Aerosolizing procedures? How do they contain

their aerosols?

Page 56: Biosafety

Risk Assessment, con’t Are personnel trained? Do

personnel understand the organism, infectious dose and symptoms?

What are their experimental procedures?

Will they be transporting the material? Shipping intra, inter-state or international?

Are they doing tissue culture? Do they have adequate

containment equipment?

Tom Pugh

Page 57: Biosafety

Risk Assessment, Con’t Are they doing this

work in-vivo? Have you consulted and discussed this with the Vets and IACUC to determine special needs and housing?

Waste issues addressed?

Pregnancy issues with the organisms?

Page 58: Biosafety

Risk Assessment, con’t Do they share their

Tissue Culture room? Do they have more than

1 Biosafety Cabinet? Occupational Health

informed and set up to receive patient or offer counseling?

Page 59: Biosafety

Accidental Spills

Evacuate area, alert personnel and cordon off so that aerosols may settle Don PPE; Cover with paper towels and apply bleach (1 part bleach : 9 parts water Allow 15 – 20 min contact time Wipe up working towards center Use tongs if broken glass is involvedIs Recombinant DNA involved?

Page 60: Biosafety

First Aid Measures

Splash to Eye or Needlestick Injury Rinse thoroughly for 15 minutes at the eyewash or

sink